Arthur C Butcher sold $1.8M of BSX
EVP& Grp Pres, MedSurg & APAC at BOSTON SCIENTIFIC CORP. 17,313 shares at an average of $104.63, traded Aug 1, 2025, filed Aug 4, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1.8M at market
- +10Share of holdings soldSold 42% of holdings
- +15Cluster4 insiders selling within 14 days
- +10Role exitThe filing reports the insider leaving
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-006985, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 1, 2025 | MOption exercise Common Stock10b5-1 | +6,952 | $27.09 | $188k | 30,552 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Common Stock10b5-1 | +6,176 | $24.55 | $152k | 36,728 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Common Stock10b5-1 | +3,176 | $22.71 | $72k | 39,904 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Common Stock10b5-1 | +1,009 | $17.26 | $17k | 40,913 | Aug 4, 2025 |
| Aug 1, 2025 | SOpen-market sale Common Stock10b5-1 | -17,313 | $104.63 | $1.8M | 23,600 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,952 | $0.00 | $0 | 6,952 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,009 | $0.00 | $0 | 1,009 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,176 | $0.00 | $0 | 6,175 | Aug 4, 2025 |
| Aug 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,176 | $0.00 | $0 | 3,177 | Aug 4, 2025 |
Related signals
Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 67Notable | BOSTON SCIENTIFIC CORP | David C Habiger director | $251k 4,450 shares | +47% | |
| 63Notable | BOSTON SCIENTIFIC CORP | Edward J Ludwig director | $203k 3,580 shares | +16% | |
| 66Notable | BOSTON SCIENTIFIC CORP | Cheryl Pegus director | $100k 1,770 shares | - | |
| 20Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $15M 160,901 shares | -10% | |
| 25Weak | BOSTON SCIENTIFIC CORP | Arthur C Butcher EVP& Grp Pres, MedSurg & APAC | $1.8M 17,313 shares | -42% | |
| 38Weak | BOSTON SCIENTIFIC CORP | Ellen M Zane director | $1.3M 12,891 shares | -35% | |
| 18Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.0M 50,000 shares | -22% | |
| 38Weak | BOSTON SCIENTIFIC CORP | Ellen M Zane director | $1.3M 12,891 shares | -35% | |
| 10Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $4.9M 50,000 shares | -22% | |
| 10Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.3M 50,000 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.